Drug Test for Qualitative Analysis of TCR α/β-Expressing Cells - Vietnam Registration 2403385ĐKLH/BYT-HTTB
Access comprehensive regulatory information for Drug Test for Qualitative Analysis of TCR α/β-Expressing Cells in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TBYT Loại C medical device is registered under number 2403385ĐKLH/BYT-HTTB and manufactured by Immunotech SAS. The authorized representative in Vietnam is CÔNG TY TNHH KỸ THUẬT NAM PHƯƠNG.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
2403385ĐKLH/BYT-HTTB
000.00.04.G18-231130-0033
Anti-TCR PAN α/β-PE
B49177
Technical Details
Anti-TCR PAN α/β-PE, which combines with the fluorescent dye, enables the qualitative and quantitative determination of TCR α/β-expressing cell populations in human biological samples by flow cytometry.
Dates and Status
Nov 06, 2024

